Results 321 to 330 of about 674,092 (373)

Pulmonary Physiology and Medicine of Diving

Seminars in Respiratory and Critical Care Medicine, 2023
Pulmonary physiology is significantly altered during underwater exposure, as immersion of the body and increased ambient pressure elicit profound effects on both the cardiovascular and respiratory systems.
K. Tetzlaff
semanticscholar   +1 more source

Analysis of Clinical Treatment of Chronic Obstructive Pulmonary Disease Complicated with Respiratory Failure in Department of Respiratory Medicine

Foreign Language Science and Technology Journal Database Medicine and Health, 2022

openalex   +2 more sources

Common cases in respiratory medicine: pulmonary embolism

BMJ, 2016
This article describes the approach to the ward round in our first patient, Mrs Mullen, who has pulmonary ...
openaire   +2 more sources

Preoperative respiratory muscle endurance training improves ventilatory capacity and prevents pulmonary postoperative complications after lung surgery: a randomized controlled trial.

European Journal of Physical and Rehabilitation Medicine, 2020
BACKGROUND Resection surgery is the main treatment for non-small cell lung cancer (NSCLC).Postoperative complications and mortality are mostly linked to respiratory failure consecutive to respiratory muscle overload. AIM We aimed to evaluate the effect
H. Laurent, S. Aubreton, G. Galvaing, B. Pereira, P. Merle, R. Richard, F. Costes, M. Filaire   +7 more
semanticscholar   +1 more source

Respiratory medicine: interstitial pneumonia, cystic fibrosis and pulmonary hypertension

Medicine, 2006
Advances in the treatment of respiratory conditions include the continuing development of disease modifying therapy for usual interstitial pneumonia (pulmonary fibrosis), and cystic fibrosis therapy has maintained improved life expectancy. Also, pulmonary rehabilitation is proving effective in optimizing physical activity in chronic obstructive ...
Siobhan Mulrennan, Martin F. Muers
openaire   +1 more source

Multi‐disciplinary collaborative consensus guidance statement on the assessment and treatment of breathing discomfort and respiratory sequelae in patients with post‐acute sequelae of SARS‐CoV‐2 infection (PASC)

PM & R : the journal of injury, function, and rehabilitation, 2021
Division of Pulmonary, Critical Care, and Sleep Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts, USA Division of Pulmonary and Critical Care, Massachusetts General Hospital, Harvard Medical School, Boston ...
J. Maley, G. A. Alba, J. Barry, M. Bartels, Talya K. Fleming, C. Oleson, L. Rydberg, S. Sampsel, J. Silver, Sabrina Sipes, Monica Verduzco Gutierrez, Jamie Wood, J. Zibrak, J. Whiteson   +13 more
semanticscholar   +1 more source

Pulmonary arteriovenous malformations- Evidence of under recognition in respiratory medicine?

4.3 Pulmonary Circulation and Pulmonary Vascular Diseases, 2016
Introduction: Pulmonary arteriovenous malformations (AVMs) affect ∼1 in 2,600 people and pose unique management challenges. Methods: US and UK Training curriculae were examined. PubMed searches were performed for “pulmonary arteriovenous malformations” or pulmonary arterial hypertension” with specified date ranges, with and without the filter ”case
Claire Shovlin, James Gossage
openaire   +1 more source

Roadmap for Advancing a New Subspecialty in Pulmonary Medicine Devoted to Chronic Respiratory Failure

Annals of the American Thoracic Society
Michelle Cao, Sherri L. Katz, John Hansen‐Flaschen   +2 more
openalex   +3 more sources

Senolytic drugs in respiratory medicine: is it an appropriate therapeutic approach?

Expert Opinion on Investigational Drugs, 2018
Introduction: Aging is the major risk factor for most of the chronic diseases. Cellular senescence is one of the main hallmarks of aging. A growing body of evidence implicates accelerated mechanisms of aging, including cellular senescence, in idiopathic ...
M. Cazzola, Mariagiuseppa Matera, P. Rogliani, L. Calzetta   +3 more
semanticscholar   +1 more source

Respiratory medicine: anti-IgE therapy, lung cancer and pulmonary hypertension

Medicine, 2006
Advances in the treatment of respiratory conditions include the use of anti-immunoglobulin E (IgE) therapy in asthma and endothelin antagonists/phosphodiesterase inhibitors in pulmonary hypertension. In the field of lung cancer, endobronchial ultrasound guided lymph node biopsy can aid in diagnosis and staging, and biological therapies are being used ...
Siobhan Mulrennan, Martin F. Muers
openaire   +1 more source